#United States #New York #Gross Law Firm #Revance Therapeutics #RVNC

Important Notice for Revance Therapeutics Shareholders

The Gross Law Firm has issued a critical alert for shareholders of Revance Therapeutics, Inc. (NASDAQ: RVNC) concerning a looming lead plaintiff deadline related to a class action lawsuit. Shareholders who acquired shares between February 29, 2024, and December 6, 2024, are strongly encouraged to respond before the March 4, 2025 deadline.

Background of the Lawsuit

According to the lawsuit, plaintiffs allege that during the specified class period, the company made materially false and misleading statements, significantly impacting the stock's market performance. The complaints assert that Revance failed to disclose pivotal information regarding a substantial breach of its Distribution Agreement with Teoxane. This agreement was crucial as it granted Revance exclusive rights to market and distribute Teoxane's line of dermal fillers.

Allegations Listed

The main points raised in the complaint include:
1. Breach of Agreement - The court claims that Revance was in significant violation of its obligations under the Distribution Agreement, which could lead to potential litigation against the company, damaging both its financial standing and reputation.
2. Risk Factors - Shareholders are informed that the aforementioned breach heightened the risk of delays or alterations in the company's tender offers.
3. Misleading Public Statements - Due to these failures, the lawsuit contends that Revance's public pronouncements were not only misleading but also materially untrue throughout the entire duration of the class period.

Next Steps for Affected Shareholders

The Gross Law Firm has made it simple for shareholders to secure their spot in this class action. Those who have purchased Revance shares during the aforementioned timeframe should register their information immediately. Participation entails no financial risk or obligation, and once registered, shareholders will receive ongoing updates about the case's progress through monitoring software set up by the law firm.

Tips for Registration

• - Ensure you have your purchase details on hand.
• - Follow the link provided by the Gross Law Firm to fill out the registration form.
• - Be mindful of the deadline—March 4, 2025—is quickly approaching.

Why Choose The Gross Law Firm?

Known nationwide, The Gross Law Firm has a long-standing reputation for advocating on behalf of investors. The firm’s dedicated mission is to ensure justice for shareholders who suffer losses due to false or omitted information from publicly-traded companies. By maintaining a steadfast commitment to corporate accountability, they are equipped to assist investors in recovering their losses effectively.

The firm’s recent announcement epitomizes its commitment to integrity, transparency, and investor rights. They invite concerned shareholders to reach out via the provided contact details for any inquiries or additional support regarding this lawsuit.

Given the potential legal implications and financial risks, affected shareholders cannot afford to overlook this notification. Acting promptly can safeguard their interests as the case unfolds.

In summary, if you believe you fall within the class period established by this lawsuit, consider reaching out to The Gross Law Firm today to protect your rights and interests as an investor.